GYS1 and myopathy: To assess if therapeutic treatment with Gys1 ASO could reverse the glycogen accumulation and myopathy in aged model, we dosed Gaa−/− mice with Gys1 ASO#2 starting at 3 months of age (Cohort 2) (Figure 3A).